Let’s Build a Bridge
Patients, physicians, health systems, clinical researchers, sponsors and regulatory authorities must work together to increase participation in clinical research.
Join the Bridging Clinical Research & Clinical Health Care Collaborative — the only forum where clinical research and health care professionals come together to envision a collaborative solution that strengthens the connection between clinical research and health care.
Stay Up To Date On Collaborative Efforts
One of the industry’s most important and well-supported events
This April, leaders from pharma, biotech, clinical research organizations, health care organizations, advocacy groups and the FDA convened to deliver on the promise of patient-centric clinical research and health care.
Keynote speakers included Janet Woodcock, M.D., director of the Center for Drug Evaluation and Research at the U.S. Food and Drug Administration, and T.J. Sharpe, cancer survivor and patient advocate. Speaking sessions, presentation and panel discussions were also presented by leaders featured below.
Returning in 2019
See why industry leaders support the collaborative
A unique opportunity for organizations of every size
The collaborative offers a unique stage for prominent industry figures to work alongside new and innovative thinkers looking to accelerate, improve or strengthen the bond between patients, physicians and clinical research efforts.
Elligo Health Research offers the only platform that brings clinical research to physician practices, accelerating the development of new pharmaceutical, biotechnology and medical device products and therapies. Our Goes Direct® approach uses state-of-the-art technology to compliantly leverage current electronic health record data and applies a proprietary, prescreening process to match protocol-eligible patients for participation in clinical studies. It is our mission to support health care providers by providing personnel, procedures, technology and infrastructure for clinical research, enabling patients to participate in research while remaining under the care of their own trusted physician. Learn more at elligodirect.com.https://www.elligohealthresearch.com/
Frenova is the world’s only contract clinical development services provider dedicated exclusively to renal research. As a Fresenius Medical Care North America company, Frenova manages a network of clinical research assets and resources including over 450 principal investigators at more than 260 sites. Frenova manages clinical trials in kidney disease and its adjacent disease areas and medical conditions. Frenova offers clinical trial sponsors access to nearly 200,000 end stage renal disease (ESRD) patients and hundreds of thousands of chronic kidney disease (CKD) patients. For more information, visit www.FrenovaRenalResearch.com.http://www.frenovarenalresearch.com/
Syneos Health is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life visit SyneosHealth.com.https://www.syneoshealth.com/
Advarra is the premier provider of IRB, IBC and global research compliance consulting services in North America for clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. By delivering exceptional client service, innovative technology and unmatched regulatory expertise, Advarra provides integrated research compliance capabilities to help make research altogether better, while putting participants first and meeting complex human research protection oversight requirements.https://www.advarra.com/
Imperial Clinical Research Services is focused on optimizing clinical trial outcomes for study sponsors, through evidence-based patient engagement programs and robust site support. Our company specializes in providing patient engagement, ISO-certified clinical translation services, and site readiness and support through study material production and global fulfillment of ancillary supplies. We have more than 40 years of industry experience and deliver our products and services into more than 110 countries annually.http://www.imperialcrs.com/
StudyKIK is a website that uses all major social media platforms to increase awareness for clinical trials. Servicing over 1300 research sites, StudyKIK owns hundreds of social media patient and caregiver communities across Instagram, Snapchat, Facebook, Twitter, and Pinterest to connect patients to clinical trials. They have addressed the clinical trial patient recruitment problem by building the tools needed for research sites and pharmaceutical companies to access, manage, and communicate with high quality patients in real-time.https://studykik.com/
SubjectWell provides risk-free patient recruitment for clinical trials. We engage the 96% of Americans who have never participated in clinical trials and we only charge for those who randomize.
Unlike traditional approaches to recruiting which are study, site and disease-specific, SubjectWell’s technology continuously recruits nationwide, informing and educating patients about clinical trials in general, at times when they are not thinking about their condition. We then contact and qualify these patients as new trials are added to our marketplace.
SubjectWell allows pharmaceutical, biotechnology, and contract research organizations to reach beyond the usual candidate populations in order to deliver results on time.
To learn more, please visit us at: http://subjectwell.com.http://subjectwell.com/
Synteract is an innovative CRO providing full-service, Phase I-IV services to biopharma companies in bringing new medicines to market. We align our operational excellence, therapeutic expertise and the right technology to support each client’s clinical development needs. Over its nearly 30-year history, Synteract’s leadership has been proven in the core development areas of oncology, neuro-degenerative disorders, rare/orphan disease, pediatrics, and dermatology, and has contributed to more than 240 product approvals in these and additional therapeutic areas.https://www.synteract.com/